Human Albumin Biotest (Human Serum Albumin)

Human Albumin Biotest is indicated for clinical situations where plasma volume expansion or albumin replacement is required.

• Treatment of hypovolemia associated with trauma, surgery, or fluid loss.
• Management of shock and severe burns to restore circulatory volume.
• Correction of hypoalbuminemia in liver disease, nephrotic syndrome, or chronic illness.
• Support during major surgical procedures to maintain oncotic pressure.
• Adjunct therapy in patients with plasma protein loss during extracorporeal circulation.

• Human Serum Albumin in Human Albumin Biotest raises plasma oncotic pressure by increasing the concentration of circulating albumin molecules. The elevated oncotic gradient draws water from the interstitial space into the vascular compartment, expanding intravascular volume. This effect helps restore colloid osmotic balance, improves tissue perfusion, and supports hemodynamic stability in patients with fluid deficits or low endogenous albumin levels.

Adverse reactions to Human Albumin Biotest are generally infrequent but may occur during or after infusion.

Common

• Mild fever or chills.
• Transient hypotension or hypertension.
• Headache or dizziness.
• Nausea or mild gastrointestinal discomfort.

Serious

• Anaphylactic or severe allergic reactions.
• Acute hemolysis or renal impairment.
• Volume overload leading to pulmonary edema.

Before administering Human Albumin Biotest, clinicians should evaluate patient history and monitor specific parameters to reduce risk.

• Assess for known hypersensitivity to human albumin or any component of the formulation.
• Evaluate fluid status and cardiac function, especially in patients with heart failure or renal insufficiency.
• Monitor vital signs and urine output during infusion to detect early signs of volume overload.
• Use caution in patients with active infection, as albumin may affect immune response.
• Adjust dose or infusion rate in patients with severe hypoalbuminemia or coagulopathy.
• Avoid rapid bolus administration; prefer controlled infusion rates.

Human Albumin Biotest can interact with other medications or solutions administered intravenously; awareness of these interactions helps maintain safety.

Avoid

• Co‑administration with incompatible solutions such as calcium‑containing fluids that may precipitate.
• Simultaneous infusion of high‑dose diuretics that could exacerbate intravascular volume shifts.
• Use with blood products that have differing osmolarity without proper mixing protocols.

Use with caution

• Concurrent vasopressor therapy, as rapid volume changes may alter hemodynamic response.
• Anticoagulants, because changes in plasma volume can affect coagulation monitoring.
• Renal replacement therapies, where albumin removal may reduce therapeutic effect.